MoonLake Immunotherapeutics (MLTX) Sector Health Care
(Current)
$18.01 0.26 (1.46%)
Open Price: 18.15
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients